연구동향 분석

Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults

주희영 박미림 이준아 박현진 박석연 김준혁 강현귀 양희철 박병규 2022년

논문상세정보
인용/피인용
' Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Irinotecan
  • Temozolomide
  • salvage therapy
  • sarcoma
  • vincristine
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
87 0

0.0%

' Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults' 의 참고문헌

  • Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors : a single center experience
  • Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma
  • VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma
    Setty BA [2018]
  • Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma : the Children’s Oncology Group
    Pappo AS [2007]
  • Trends in childhood cancer incidence in the U.S. (1992-2004)
    Linabery AM [2008]
  • Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma
    Wagner LM [2007]
  • Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know
    Nishino M [2010]
  • Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide(VOIT)for children with relapsed or refractory solid tumors : a Children’s Oncology Group phase I consortium study
    Wagner LM [2010]
  • Irinotecan and temozolomide in recurrent Ewing sarcoma : an analysis in 51 adult and pediatric patients
    Palmerini E [2018]
  • Irinotecan and temozolomide for Ewing sarcoma : the Memorial Sloan-Kettering experience
    Casey DA [2009]
  • Irinotecan and temozolamide treatment for relapsed Ewing sarcoma : a single-center experience and review of the literature
    Kurucu N [2015]
  • Incidence and Survival of Childhood Cancer in Korea
    박현진 [2016]
  • Ifosfamide, carboplatin, and etoposide(ICE)reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma : the Children’s Cancer Group(CCG)experience
  • Gemcitabine and docetaxel(GEMDOX)for the treatment of relapsed and refractory pediatric sarcomas
    Rapkin L [2012]
  • Extended phase I evaluation of vincristine, irinotecan, temozolomide, and antibiotic in children with refractory solid tumors
  • Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors : a Pediatric Oncology Group phase II study
  • Conditional survival of pediatric, adolescent, and young adult soft tissue sarcoma and bone tumor patients
    Ou JY [2017]
  • Childhood nonrhabdomyosarcoma soft tissue sarcomas are not adult-type tumors
    Spunt SL [2006]
  • Cefixime allows greater dose escalation of oral irinotecan : a phase I study in pediatric patients with refractory solid tumors
    Furman WL [2006]
  • Camptothecin-based regimens for treatment of ewing sarcoma : past studies and future directions
    Wagner L [2011]